Published in Medical Letter on the CDC and FDA, May 15th, 2005
Nicholas Teti, chairman, CEO and president of Inamed, released the following statement with respect to the FDA panel decision to approve Mentor's PMA: "Inamed views [this] panel decision as curious and inconsistent with the decision reached by the panel [previously] on Inamed's PMA - we look forward to working with Crawford and FDA staff on addressing these...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.